Battle over COVID-19 booster shots ends with split decision

The Food and Drug Administration voted against approving a booster shoot of the Pfizer vaccine for Americans 16 and older, but the committee did vote in favor of 3rd doses for people 65 and older. If vaccine efficacy wanes over time, what happens from here? NBC’s Kathy Park has this week’s Sunday Focus.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting